Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial

BACKGROUND: Introduction of calcineurin inhibitors had led to improved survival rates in liver transplant recipients. However, long-term use of calcineurin inhibitors is associated with a higher risk of chronic renal failure, neurotoxicity, de novo malignancies, recurrence of hepatitis C viral (HCV)...

Descripción completa

Detalles Bibliográficos
Autores principales: Nashan, Bjorn, Schemmer, Peter, Braun, Felix, Dworak, Markus, Wimmer, Peter, Schlitt, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384314/
https://www.ncbi.nlm.nih.gov/pubmed/25873064
http://dx.doi.org/10.1186/s13063-015-0626-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384314/
https://www.ncbi.nlm.nih.gov/pubmed/25873064
http://dx.doi.org/10.1186/s13063-015-0626-0

Ejemplares similares